Search results for "staging"

showing 10 items of 740 documents

Trends in Frequency and Management of Obstructing Colorectal Cancers in a Well-Defined Population

2007

Few population-based studies investigate obstructing colorectal cancers. This study was designed to describe trends in their frequency and management. Data were obtained for 13,331 colorectal cancers registered by the population-based cancer registry of Burgundy, France, between the years 1976 and 2000. Obstructing cancers represented 8.3 percent of all colorectal cancers. This proportion was stable throughout the study. Resection for cure increased from 54.9 percent (1976–1980) to 71.4 percent (1996–2000; P = 0.011). Using multivariate analysis, site of cancer and period of diagnosis were the only factors significantly associated to a curative resection. Postoperative mortality for obstruc…

Malemedicine.medical_specialtyColorectal cancerPopulationAdenocarcinomaGastroenterologySurgical oncologyInternal medicineHumansMedicineHospital MortalityRegistrieseducationMass screeningAgedNeoplasm StagingAged 80 and overeducation.field_of_studybusiness.industryIncidenceIncidence (epidemiology)Age FactorsGastroenterologyCancerGeneral MedicineMiddle Agedmedicine.diseaseColorectal surgeryCancer registryFemaleFranceColorectal NeoplasmsbusinessIntestinal ObstructionDiseases of the Colon & Rectum
researchProduct

Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary.

2015

The implementation of preoperative chemoradiation combined with total mesorectal excision has reduced local recurrence rates in rectal cancer. However, the use of both types of treatment in upper rectal cancer is controversial.The purpose of this work was to assess oncological results after radical resection of upper rectal cancers compared with sigmoid, middle, and lower rectal cancers and to determine risk factors for local recurrence in upper rectal cancer.This was a retrospective analysis of prospectively collected data.This study was conducted in a tertiary care referral hospital in Valencia, Spain.Analysis included 1145 patients who underwent colorectal resection with primary curative…

Malemedicine.medical_specialtyColorectal cancerUnnecessary ProceduresPreoperative careDisease-Free SurvivalRisk FactorsPreoperative CareMedicineHumansSurvival rateAgedNeoplasm StagingRetrospective StudiesPreoperative chemoradiotherapybusiness.industryRectal NeoplasmsGastroenterologyFollow up studiesRetrospective cohort studyGeneral MedicineChemoradiotherapy Adjuvantmedicine.diseasePrognosisTotal mesorectal excisionMagnetic Resonance ImagingSurvival RateSigmoid NeoplasmsTreatment OutcomeFemaleRadiologyNeoplasm Recurrence LocalbusinessChemoradiotherapyFollow-Up StudiesDiseases of the colon and rectum
researchProduct

Delay in the Diagnosis of Breast and Colorectal Cancer in People With Severe Mental Disorders

2020

Background People with severe mental disorders have a worse cancer prognosis, with higher mortality rates than the general population, and this could be partially attributed to a later detection. Breast cancer and colorectal cancer have mass population screenings in Spain, but the influence in early diagnosis is unknown in persons with severe mental disorders. Objective To compare the severity of breast and colorectal cancers at diagnosis in people with and without mental disorders. Methods This was an observational, retrospective, case-control study with 1:2 matching performed in Eastern Spain. Data were retrieved for analysis from electronic medical records. Results The study included 111…

Malemedicine.medical_specialtyDelayed DiagnosisColorectal cancerPopulationBreast NeoplasmsMental disordersColorectal neoplasms03 medical and health sciences0302 clinical medicineBreast cancerInternal medicineCancer screeningOdds RatioHumansMedicineeducationEarly Detection of CancerAgedRetrospective Studieseducation.field_of_study030504 nursingOncology (nursing)business.industryMental DisordersRetrospective cohort studyOdds ratioMiddle Agedmedicine.diseaseMental healthOncologySpainCase-Control StudiesEarly detection of cancer030220 oncology & carcinogenesisRelative riskNeoplasm stagingFemaleBreast neoplasmsColorectal Neoplasms0305 other medical sciencebusinessCancer Nursing
researchProduct

Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral…

2020

Objectives: The aim of this multicenter study was to investigate the prognostic role of type 2 diabetes mellitus (T2DM) comorbidity in a large multi-institutional cohort of patients with primary T1HG/G3 non–muscle-invasive bladder cancer (NMIBC) treated with transurethral resection of the bladder (TURB). Materials and methods: A total of 1,172 patients with primary T1 HG/G3 who had NMIBC on re-TURB and who received adjuvant intravesical bacillus Calmette-Guérin therapy with maintenance were included. Endpoints were recurrence-free survival and progression-free survival. Results: A total of 231 (19.7%) of patients had T2DM prior to TURB. Five-year recurrence-free survival estimates were 12.5…

Malemedicine.medical_specialtyDiabetes mellituUrologymedicine.medical_treatment030232 urology & nephrologyUrologyCystectomyResection03 medical and health sciences0302 clinical medicineDiabetes mellitusHigh gradeAdjuvants ImmunologicUrethraRecurrenceDiabetes mellitusmedicineHumansIn patientNeoplasm InvasivenessAgedNeoplasm StagingRetrospective StudiesBladder cancerProgressionbusiness.industryHigh riskBladder cancerType 2 Diabetes MellitusMiddle Agedmedicine.diseasePrognosisComorbidityProgression-Free Survival3. Good healthBladder cancer; Diabetes mellitus; High grade; High risk; Progression; RecurrenceSettore MED/24OncologyDiabetes Mellitus Type 2Urinary Bladder NeoplasmsChemotherapy Adjuvant030220 oncology & carcinogenesisCohortBCG VaccineFemaleNeoplasm GradingbusinessAdjuvantUrologic oncology
researchProduct

Preoperative detection of intrathoracic tumor spread of esophageal cancer: endosonography versus computed tomography.

1991

The results of endosonography and computed tomography, using an optimized CT technique, have been compared in the preoperative detection of intrathoracic tumor spread of esophageal cancer. In 22/40 patients with esophageal tumors complete passage of the ultrasonic endoscope was possible. Endosonography was superior to CT in the assessment of early stage of esophageal tumor (T1-2). Out of 9 tumors confined to the esophageal wall, 8 were classified correctly by endosonography and only 5 by computed tomography. The results in advanced T3 and T4 tumors (13 patients) were comparable following endosonography and computed tomography. Endosonography is an important means of selecting patients with …

Malemedicine.medical_specialtyEndoscopeEsophageal NeoplasmsComputed tomographyEsophageal tumorsInternal medicinePreoperative CaremedicineHumansStage (cooking)Neoplasm StagingUltrasonographymedicine.diagnostic_testbusiness.industryCarcinomaHepatologyEsophageal cancerMiddle AgedThoracic Neoplasmsmedicine.diseasePrognosisLymphatic MetastasisSurgeryFemaleRadiologyComplicationbusinessTomography X-Ray ComputedAbdominal surgerySurgical endoscopy
researchProduct

Prospective evaluation of the macroscopic types and location of early Barrett’s neoplasia in 380 lesions

2007

The macroscopic appearance of early gastric cancers, classified according to the Japanese criteria, has been shown to be an important prognostic factor for local endoscopic therapy. No prospective data about the distribution of macroscopic types and their location in early Barrett's neoplasia are available, however. The present study was conducted to evaluate the clinical applicability of this macroscopic classification and to analyze the relative proportions of the different gross types in early Barrett's neoplasms and the correlation between the macroscopic classification and the stage or grade of differentiation.A total of 344 patients with 380 Barrett's neoplastic lesions who were refer…

Malemedicine.medical_specialtyEsophageal NeoplasmsBiopsyVideo RecordingSeverity of Illness IndexGastroenterologyEndoscopy GastrointestinalBarrett EsophagusInternal medicinemedicineCarcinomaHumansProspective StudiesIntestinal MucosaStage (cooking)EsophagusStomach cancerProspective cohort studyAgedNeoplasm StagingObserver VariationIntraepithelial neoplasiamedicine.diagnostic_testEsophageal diseasebusiness.industryGastroenterologyReproducibility of ResultsPrognosismedicine.diseaseEndoscopyEsophagectomymedicine.anatomical_structureDisease ProgressionFemalebusinessFollow-Up StudiesEndoscopy
researchProduct

Management of pre-malignant and malignant lesions by endoscopic resection

2003

Endoscopic resection (ER) has gained more and more importance in the treatment of early gastrointestinal neoplasia over the last few years. The choice of the different available techniques depends on the site, the macroscopic type of the tumour and the personal experience of the endoscopist. The 'suck-and-cut' technique with ligation device or cap should be favoured to normal strip biopsy in the oesophagus because of the size of the resected specimen and its technical feasibility. A recently described method of ER in the stomach is the circumferential mucosal incision with a type of needle-knife and subsequent en-bloc resection following prior injection under the lesions. ER of high-grade i…

Malemedicine.medical_specialtyEsophageal NeoplasmsColorectal cancerEndoscopic mucosal resectionRisk AssessmentBarrett EsophagusStomach NeoplasmsmedicineHumansMinimally Invasive Surgical ProceduresGastrointestinal NeoplasmsNeoplasm StagingClinical Trials as TopicIntraepithelial neoplasiamedicine.diagnostic_testbusiness.industryStomachBiopsy NeedleGastroenterologyEndoscopymedicine.diseaseImmunohistochemistrydigestive system diseasesEndoscopySurgeryMajor duodenal papillaTreatment Outcomemedicine.anatomical_structureAdenocarcinomaFemaleLigationbusinessPrecancerous ConditionsFollow-Up StudiesBest Practice & Research Clinical Gastroenterology
researchProduct

Positron Emission Tomography for Staging Esophageal Cancer: Does It Lead to a Different Therapeutic Approach?

2003

Accurate preoperative staging is essential for the indication and selection of the appropriate surgical procedure in patients with esophageal cancer. The present prospective study was designed to determine if the preoperative use of (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) increases the accuracy of staging esophageal cancer compared with computed tomography (CT) and if it thereby leads to a different therapeutic approach. A total of 58 patients, 46 men and 12 women (mean age 61 years), with histologic proof of esophageal carcinoma underwent FDG-PET of the neck, chest, and abdomen, as well as CT of the chest and abdomen, to determine tumor stage. FDG-PET and CT data we…

Malemedicine.medical_specialtyEsophageal NeoplasmsSensitivity and SpecificityPreoperative careMetastasisPreoperative CareHumansMedicineProspective StudiesEsophagusLymph nodeAgedNeoplasm Stagingmedicine.diagnostic_testbusiness.industryEsophageal diseaseCarcinomaReproducibility of ResultsMiddle AgedEsophageal cancermedicine.diseasemedicine.anatomical_structurePositron emission tomographyLymphatic MetastasisFemaleSurgeryRadiologyTomography X-Ray ComputedbusinessTomography Emission-ComputedAbdominal surgeryWorld Journal of Surgery
researchProduct

Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38…

2019

IF 3.287 (2017); International audience; IntroductionCombination of cisplatine and Gemcitabine (CisGem) is the reference 1st line Chemotherapy in patients with advanced biliary cancer. FOLFIRINOX demonstrated an overall survival superiority when compared to gemcitabine in 1st line for patients with metastatic pancreatic adenocarcinoma. Because of similarities between pancreatic and biliary cancers, we proposed a randomized trial comparing mFOLFIRINOX and CisGEm.AimPRODIGE38-AMEBICA is a phase II/III trial evaluating efficacy of modifed FOLFIRINOX (D1 bolus removed) or CisGEm on patients with locally advanced non resectable or metastatic biliary tract cancer.Patients and methodsMain inclusio…

Malemedicine.medical_specialtyFOLFIRINOXmedicine.medical_treatmentModified folfirinoxLeucovorinAntineoplastic Agents[SDV.CAN]Life Sciences [q-bio]/CancerAdvanced biliary cancerIrinotecanDeoxycytidineGastroenterology03 medical and health sciences0302 clinical medicineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsCarcinomaHumansMedicineNeoplasm InvasivenessNeoplasm StagingChemotherapyHepatologybusiness.industryGallbladderCarcinomaGastroenterologyMetastatic Pancreatic Adenocarcinomamedicine.diseaseGemcitabinePrimary tumorGemcitabine3. Good healthOxaliplatinmedicine.anatomical_structureBile Duct NeoplasmsBiliary tract030220 oncology & carcinogenesisFemale030211 gastroenterology & hepatologyFluorouracilFranceCisplatinDrug Monitoringbusinessmedicine.drug
researchProduct

End-Stage Pancreatic Adenocarcinoma Presenting as a Sister Mary Joseph's Nodule.

2017

[No abstract available]

Malemedicine.medical_specialtyFatal outcomeSkin NeoplasmsAdenocarcinomaDiagnosis Differential03 medical and health sciences0302 clinical medicineFatal OutcomeX ray computedMedicineHumansStage (cooking)Sister Mary Joseph's NoduleNeoplasm StagingUmbilicusbusiness.industryGeneral MedicineMiddle Agedmedicine.diseasePancreatic Neoplasms030220 oncology & carcinogenesisAdenocarcinoma030211 gastroenterology & hepatologyNeoplasm stagingRadiologybusinessTomography X-Ray Computedpancreatic adenocarcinoma sister Mary Joseph's noduleBiomarkersThe American surgeon
researchProduct